Les Barons de la Bourse

Stephen A. Berenson

Age : 60

Patrimoine public : 5 134 386 USD

Principales sociétés :

Moderna, Inc. -

Seres Therapeutics, Inc.

Synthèse

Stephen A. Berenson holds the position of Chairman at Seres Therapeutics, Inc., Chairman at Cellarity Inc. and Managing Partner at Flagship Pioneering. Mr. Berenson is also on the board of 5 other companies.

Mr. Berenson received an undergraduate degree from Massachusetts Institute of Technology.

Postes et responsabilités de Stephen A. Berenson

Nom	Titre	Depuis
Moderna, Inc. (Recherche biotechnologique et médicale)	Independent Non-Executive Director	2017
Seres Therapeutics, Inc. (Recherche biotechnologique et médicale)	Chairman	2019
Cellarity Inc.	Chairman	-
ModernaTX, Inc.	Director	2017
CiBO Technologies, Inc.	Director	-
The Mahaiwe Performing Arts Center	Trustee	-
Repertoire Immune Medicines, Inc.	Director	-
Flagship Pioneering	Managing Partner	-

Participations de Stephen A. Berenson

Nom	Actions	%	Valorisation
Moderna, Inc. (MRNA) (Recherche biotechnologique et médicale)	20 098	0,0050%	5 104 490 USD
Seres Therapeutics, Inc. (MCRB) (Recherche biotechnologique et médicale)	3 589	0,0039%	29 896 USD

Stephen A. Berenson: Réseau personnel

Nom	Sociétés liées
Noubar Afeyan	Moderna, Inc. Seres Therapeutics, Inc. Repertoire Immune Medicines, Inc. Cellarity Inc. Flagship Pioneering CiBO Technologies, Inc. ModernaTX, Inc.
Stéphane Bancel	Moderna, Inc. Flagship Pioneering ModernaTX, Inc.
Marcello Damiani	Moderna, Inc. Cellarity Inc. ModernaTX, Inc.
Shannon Klinger	Moderna, Inc. ModernaTX, Inc.
Stephen Hoge	Moderna, Inc. ModernaTX, Inc.
Elizabeth G. Nabel	Moderna, Inc. ModernaTX, Inc.
Robert Langer	Moderna, Inc. ModernaTX, Inc.
Paul Sagan	Moderna, Inc. ModernaTX, Inc.
Paul R. Biondi	Seres Therapeutics, Inc.
Matthew R. Henn	Seres Therapeutics, Inc.